CAS: 196808-45-4 - 2(S)-(2-Benzoylphenylamino)-3-[4-[2-(5-methyl-2-phenyloxazol-4-yl)ethoxy]phenyl]propionic acid
Fórmula:C34H30N2O5
InChI:InChI=1S/C34H30N2O5/c1-23-29(36-33(41-23)26-12-6-3-7-13-26)20-21-40-27-18-16-24(17-19-27)22-31(34(38)39)35-30-15-9-8-14-28(30)32(37)25-10-4-2-5-11-25/h2-19,31,35H,20-22H2,1H3,(H,38,39)/t31-/m0/s1
Chave InChI:InChIKey=ZZCHHVUQYRMYLW-HKBQPEDESA-N
SMILES:O=C(O)C(NC=1C=CC=CC1C(=O)C=2C=CC=CC2)CC3=CC=C(OCCC=4N=C(OC4C)C=5C=CC=CC5)C=C3
- Sinónimos:
- <span class="text-smallcaps">L</span>-Tyrosine, N-(2-benzoylphenyl)-O-[2-(5-methyl-2-phenyl-4-oxazolyl)ethyl]-
- Farglitazar
- G1 262570
- Gi 262570X
- Gi-262570
- N-(2-Benzoylphenyl)-O-[2-(5-methyl-2-phenyl-4-oxazolyl)ethyl]-<span class="text-smallcaps">L</span>-tyrosine
- N-(2-Benzoylphenyl)-O-[4-[2-(5-methyl-2-phenyloxazol-4-yl)ethyl]-L-tyrosine
- N-(2-benzoylphenyl)-O-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethyl]-L-tyrosine
Marca | Dados do produto | Pureza | Gama de preços | Estimativa de entrega |
---|---|---|---|---|
N-(2-Benzoylphenyl)-O-[2-(5-methyl-2-phenyl-4-oxazolyl)ethyl]-L-tyrosine REF: TR-F102370CAS: 196808-45-4 | - - - | 2.134,00 € | Ter 21 Jan 25 | |
Farglitazar REF: 3D-WHA80845CAS: 196808-45-4 | Min. 95% | A consultar | Ter 21 Jan 25 | |
Farglitazar REF: TM-T27303CAS: 196808-45-4 | 99.40% - 99.65% | 276,00 €~1.862,00 € | Ter 28 Jan 25 |
N-(2-Benzoylphenyl)-O-[2-(5-methyl-2-phenyl-4-oxazolyl)ethyl]-L-tyrosine
Produto ControladoRef: TR-F102370
750mg | 2.134,00 € |
Farglitazar
Ref: 3D-WHA80845
25mg | A consultar | ||
50mg | A consultar | ||
100mg | A consultar | ||
250mg | A consultar | ||
500mg | A consultar |
Farglitazar
Ref: TM-T27303
1mg | 276,00 € | ||
5mg | 679,00 € | ||
10mg | 928,00 € | ||
25mg | 1.430,00 € | ||
50mg | 1.862,00 € |